Showing results (81-90 of 92) with videos related to
Sort By:
Pageof 10
Nature Structural & Molecular Biology|January 26, 2010
Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophyHongqing Du, Melissa S Cline, Robert J Osborne, et al.Cancer Treatment Reports|February 1, 1987
High-dose lymphoblastoid interferon in advanced renal cell carcinoma: an Eastern Cooperative Oncology Group StudyD L Trump, P J Elson, E C Borden, et al.European Geriatric Medicine|March 2, 2022
Albumin and C-reactive protein relate to functional and body composition parameters in patients admitted to geriatric rehabilitation after acute hospitalization: findings from the RESORT cohortJeanine M Van Ancum, Camilla S L Tuttle, René Koopman, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 20, 2020
Efficacy and Safety of Continued Treatment With Mirikizumab in a Phase 2 Trial of Patients With Ulcerative ColitisWilliam J Sandborn, Marc Ferrante, Bal R Bhandari, et al.Gastroenterology|September 8, 2019
Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative ColitisWilliam J Sandborn, Marc Ferrante, Bal R Bhandari, et al.Journal of Hematology & Oncology|March 23, 2017
A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemiaSaroj Vadhan-Raj, Rafat Abonour, Jonathan W Goldman, et al.AIDS Research and Human Retroviruses|March 19, 2002
Increased replication of non-syncytium-inducing HIV type 1 isolates in monocyte-derived macrophages is linked to advanced disease in infected childrenDaniel L Tuttle, Cynthia B Anders, M Janette Aquino-De Jesus, et al.Gastroenterology|November 8, 2021
Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Crohn's DiseaseBruce E Sands, Laurent Peyrin-Biroulet, Jaroslaw Kierkus, et al.Science Translational Medicine|June 9, 2022
The anti-SARS-CoV-2 monoclonal antibody bamlanivimab minimally affects the endogenous immune response to COVID-19 vaccinationRobert J Benschop, Jay L Tuttle, Lin Zhang, et al.Ecotoxicology and Environmental Safety|June 1, 2017
Reprint of: Overview of avian toxicity studies for the Deepwater Horizon Natural Resource Damage AssessmentS J Bursian, C R Alexander, D Cacela, et al.Pageof 10